Skip to main content

Strategic intelligence for biopharma

Finished analysis.
Verified by scientists.

Competitive landscapes, target product profiles, and conference intelligence for biopharma decisions.

Our AI agents and scientists work over the same connected evidence, with experts shaping the analysis throughout.

Our clients already include 4 of the largest pharmaceutical companies.

Scientific rigor. Connected sources. A finished deliverable.Explore the work

01 / Our analysis

Finished analysis,
ready to use.

More evidence, sooner. More options before you commit. Start with the question your team needs to answer.

Where should we focus?

Competitive
landscapes

Compare assets, indications, and competitors. Understand the evidence behind the opportunity.

Asset landscapes · Gap analysis · Portfolio intelligence
Explore

How will we differentiate?

Target product
profiles

Define your product against clinical and commercial benchmarks, with the reasoning made clear.

Clinical benchmarks · Target positioning · Evidence review
Explore

What changes our strategy?

Conference
intelligence

Know what changed and what it means. Put new evidence in the context of your competitive landscape.

Conference readiness · Evidence updates · Strategic briefings
Explore
Delivered in the format your team needs.Dashboards / Reports / Executive decks / Structured data

02 / The Epistemic approach

One system, from
question to conclusion.

Scientific judgment, from the start.

Scientists shape the scope, evidence gathering, interpretation, and conclusions. Our agents and proprietary knowledge graph make that work possible at scale.

Specialized AI agents

Investigate your question across publications, trials, regulatory documents, and other relevant sources.

Deliberate evidence gathering
Our knowledge graph

Connect biomedical entities, clinical evidence, and source context so findings can be explored together.

Connected, traceable evidence
Our scientists

Shape the research, challenge the reasoning, and guide the interpretation and conclusions throughout.

Scientific expertise throughout

Start with your decision. Agree the scope, format, and update cadence.

How it works

03 / In practice

Real work.
Meaningful impact.

From a single strategic question to ongoing portfolio intelligence. Here is what that looks like in practice.

Conference intelligence

30+ conferences per year

Readiness and evidence updates for a top-20 pharma company.

Target product profiles

Months days for TPP delivery

A top-20 pharma pilot expanded into a multi-phase program.

Competitive intelligence

Portfolio-wide from one indication

An oncology landscape grew into ongoing portfolio intelligence.

Results from individual engagements. Timing depends on scope, evidence availability, and scientific review.

Working with Epistemic

Know what
you’re getting.

A clear scope. Evidence you can inspect. Analysis built around your decision.

What does my team receive?

A finished competitive landscape, target product profile, conference briefing, or related strategic analysis. We agree the question, evidence scope, and output format with you, then deliver through dashboards, reports, executive decks, or structured data.

How are scientists involved?

Our life-science experts shape the scope, evidence gathering, interpretation, and conclusions throughout the work. They challenge the reasoning and review the analysis before delivery. Source references let your team inspect the evidence behind the findings.

Can you keep the analysis current?

Yes. We agree what to refresh and on what cadence, based on your decision and how the evidence changes. The scope includes the evidence to revisit, the outputs to update, and the scientific review required.

Your next decision starts here

What decision is
your team facing?

Bring us your question. Let’s define the analysis that moves you forward.

Talk to our team